These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16894207)

  • 41. pol gene diversity of five human immunodeficiency virus type 1 subtypes: evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D.
    Cornelissen M; van den Burg R; Zorgdrager F; Lukashov V; Goudsmit J
    J Virol; 1997 Sep; 71(9):6348-58. PubMed ID: 9261352
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The zinc finger of nucleocapsid protein of Friend murine leukemia virus is critical for proviral DNA synthesis in vivo.
    Yu Q; Darlix JL
    J Virol; 1996 Sep; 70(9):5791-8. PubMed ID: 8709195
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incorporation of pol into human immunodeficiency virus type 1 Gag virus-like particles occurs independently of the upstream Gag domain in Gag-pol.
    Cen S; Niu M; Saadatmand J; Guo F; Huang Y; Nabel GJ; Kleiman L
    J Virol; 2004 Jan; 78(2):1042-9. PubMed ID: 14694138
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A large deletion in the matrix domain of the human immunodeficiency virus gag gene redirects virus particle assembly from the plasma membrane to the endoplasmic reticulum.
    Fäcke M; Janetzko A; Shoeman RL; Kräusslich HG
    J Virol; 1993 Aug; 67(8):4972-80. PubMed ID: 8331736
    [TBL] [Abstract][Full Text] [Related]  

  • 45. RNA packaging signal of human immunodeficiency virus type 1.
    Hayashi T; Shioda T; Iwakura Y; Shibuta H
    Virology; 1992 Jun; 188(2):590-9. PubMed ID: 1585635
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interactions between HIV-1 Gag and Viral RNA Genome Enhance Virion Assembly.
    Dilley KA; Nikolaitchik OA; Galli A; Burdick RC; Levine L; Li K; Rein A; Pathak VK; Hu WS
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28539452
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of deletion mutations in the capsid region of human immunodeficiency virus type 1 that affect particle formation and Gag-Pol precursor incorporation.
    Srinivasakumar N; Hammarskjöld ML; Rekosh D
    J Virol; 1995 Oct; 69(10):6106-14. PubMed ID: 7666514
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of human immunodeficiency virus type 1 Pr160 gag-pol mutants with truncations downstream of the protease domain.
    Liao WH; Wang CT
    Virology; 2004 Nov; 329(1):180-8. PubMed ID: 15476885
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel patterns of nevirapine resistance-associated mutations of human immunodeficiency virus type 1 in treatment-naïve patients.
    Hachiya A; Gatanaga H; Kodama E; Ikeuchi M; Matsuoka M; Harada S; Mitsuya H; Kimura S; Oka S
    Virology; 2004 Oct; 327(2):215-24. PubMed ID: 15351209
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutations in the N-terminal domain of human immunodeficiency virus type 1 nucleocapsid protein affect virion core structure and proviral DNA synthesis.
    Berthoux L; Péchoux C; Ottmann M; Morel G; Darlix JL
    J Virol; 1997 Sep; 71(9):6973-81. PubMed ID: 9261426
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Subtype-associated differences in HIV-1 reverse transcription affect the viral replication.
    Iordanskiy S; Waltke M; Feng Y; Wood C
    Retrovirology; 2010 Oct; 7():85. PubMed ID: 20939905
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Determinants of Moloney murine leukemia virus Gag-Pol and genomic RNA proportions.
    Johnson SF; Collins JT; D'Souza VM; Telesnitsky A
    J Virol; 2014 Jul; 88(13):7267-75. PubMed ID: 24741085
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identifying the assembly intermediate in which Gag first associates with unspliced HIV-1 RNA suggests a novel model for HIV-1 RNA packaging.
    Barajas BC; Tanaka M; Robinson BA; Phuong DJ; Chutiraka K; Reed JC; Lingappa JR
    PLoS Pathog; 2018 Apr; 14(4):e1006977. PubMed ID: 29664940
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Infectivity and replication capacity of drug-resistant human immunodeficiency virus type 1 variants isolated during primary infection.
    Simon V; Padte N; Murray D; Vanderhoeven J; Wrin T; Parkin N; Di Mascio M; Markowitz M
    J Virol; 2003 Jul; 77(14):7736-45. PubMed ID: 12829813
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Restriction of HIV-1 replication in intestinal cells is genetically controlled by the gag-pol region of the HIV-1 genome.
    De Mareuil J; Guettari N; Bolmont C; Salaun D; Baillon JG; Hostomsky Z; Hirsch I
    Virology; 1995 Feb; 207(1):160-7. PubMed ID: 7532883
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanisms of human immunodeficiency virus type 2 RNA packaging: efficient trans packaging and selection of RNA copackaging partners.
    Ni N; Nikolaitchik OA; Dilley KA; Chen J; Galli A; Fu W; Prasad VV; Ptak RG; Pathak VK; Hu WS
    J Virol; 2011 Aug; 85(15):7603-12. PubMed ID: 21613401
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Compensatory point mutations in the human immunodeficiency virus type 1 Gag region that are distal from deletion mutations in the dimerization initiation site can restore viral replication.
    Liang C; Rong L; Laughrea M; Kleiman L; Wainberg MA
    J Virol; 1998 Aug; 72(8):6629-36. PubMed ID: 9658109
    [TBL] [Abstract][Full Text] [Related]  

  • 58. RU5 of Mason-Pfizer monkey virus 5' long terminal repeat enhances cytoplasmic expression of human immunodeficiency virus type 1 gag-pol and nonviral reporter RNA.
    Hull S; Boris-Lawrie K
    J Virol; 2002 Oct; 76(20):10211-8. PubMed ID: 12239296
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Requirement of the Pr55gag precursor for incorporation of the Vpr product into human immunodeficiency virus type 1 viral particles.
    Lavallée C; Yao XJ; Ladha A; Göttlinger H; Haseltine WA; Cohen EA
    J Virol; 1994 Mar; 68(3):1926-34. PubMed ID: 8107252
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The selective packaging and annealing of primer tRNALys3 in HIV-1.
    Kleiman L; Halwani R; Javanbakht H
    Curr HIV Res; 2004 Apr; 2(2):163-75. PubMed ID: 15078180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.